Scope Biosciences
PrivateLast Round
Seed
Jun 16, 2025
Total Funding Raised
$6.73M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Scope Biosciences is a biotechnology company that provides a CRISPR-Cas based molecular diagnostics platform, scopeDx®, for on-site pathogen testing in the agriculture and healthcare industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scope Biosciences Comparables
Compare Scope Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hypercell Technologies | 77% | |
| CrisprBits | 76% | |
| Agdia, Inc. | 74% |
Scope Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 16, 2025 | ||||
| Grant | Mar 7, 2024 | ||||
| Seed | Oct 23, 2023 | ||||
| Seed | Nov 5, 2021 |
Key People
Founding team and executive leadership
Scope Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| SHIFT Invest | Seed |
| Oost NL | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 139% MoM, reaching 1.7K.
- Jul 26, 2026
Monthly visitors grew 44% MoM.
Scope Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Scope Biosciences's valuation, stock price, and market status.
Is Scope Biosciences a public or private company?
Scope Biosciences is a private company.
What is the current stock price of Scope Biosciences?
Scope Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Scope Biosciences worth (valuation)?
Valuation information for Scope Biosciences is not publicly available.
Can I buy Scope Biosciences stock?
Scope Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Scope Biosciences's last funding round?
Scope Biosciences's most recent funding round was Seed on June 16, 2025.
Who are the main investors in Scope Biosciences?
Key investors in Scope Biosciences include SHIFT Invest, Oost NL.
Will Scope Biosciences IPO soon?
No public IPO plans have been announced for Scope Biosciences.
How can I track Scope Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Scope Biosciences's secondary market activity and sign up for updates.